The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

BACKGROUND: Alzheimer’s disease (AD) is the most commonly occurring form of dementia. It is predominantly a disease of later life, affecting 5% of those over 65 in the UK. OBJECTIVES: Review and update guidance to the NHS in England and Wales on the clinical effectiveness and cost-effectiveness of d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Bond, M, Rogers, G, Peters, J, Anderson, R, Hoyle, M, Miners, A, Moxham, T, Davis, S, Thokala, P, Wailoo, A, Jeffreys, M, Hyde, C
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780923/
https://ncbi.nlm.nih.gov/pubmed/22541366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta16210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados